MARC details
000 -LÍDER |
fixed length control field |
05063cam a2200649Ki 4500 |
001 - NÚMERO DE CONTROL |
control field |
u380224 |
003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
control field |
SIRSI |
005 - FECHA Y HORA DE LA ULTIMA TRANSACCIÓN |
control field |
20160812084637.0 |
006 - ELEMENTOS DE LONGITUD FIJA - CARACTERÍSTICAS DE MATERIALES ADICIONALES - INFORMACIÓN GENERAL |
fixed length control field |
m o d |
007 - CAMPO FIJO DE DESCRIPCIÓN FIJA--INFORMACIÓN GENERAL |
fixed length control field |
cr cnu---unuuu |
008 - ELEMENTOS DE LONGITUD FIJA -- INFORMACIÓN GENERAL |
fixed length control field |
130909s2014 ne a ob 001 0 eng d |
040 ## - FUENTE DE CATALOGACIÓN |
Original cataloging agency |
NT |
Language of cataloging |
eng |
Description conventions |
rda |
-- |
pn |
Transcribing agency |
NT |
Modifying agency |
UIU |
-- |
OPELS |
-- |
YDXCP |
-- |
BUF |
-- |
OPELS |
-- |
OCLCF |
-- |
UIU |
-- |
OCLCQ |
-- |
OCLCO |
-- |
VAM |
-- |
VZR |
019 ## - |
-- |
861477955 |
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
International Standard Book Number |
9780123946324 |
Qualifying information |
(electronic bk.) |
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
International Standard Book Number |
0123946328 |
Qualifying information |
(electronic bk.) |
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
Canceled/invalid ISBN |
9780123942951 |
020 ## - NÚMERO INTERNACIONAL NORMALIZADO PARA LIBROS |
Canceled/invalid ISBN |
0123942950 |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
DEBSZ |
System control number |
405350600 |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
NLGGC |
System control number |
369326989 |
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) |
OCLC library identifier |
NZ1 |
System control number |
15195162 |
050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
Classification number |
RC271.G45 |
Item number |
G485 2014 |
082 04 - NÚMERO DE CLASIFICACIÓN DECIMAL DEWEY |
Classification number |
616.994042 |
Edition number |
23 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
TEFA |
245 00 - MENCIÓN DE TITULO |
Title |
Gene therapy of cancer |
Medium |
[recurso electrónico] : |
Remainder of title |
translational approaches from preclinical studies to clinical implementation / |
Statement of responsibility, etc. |
edited by Edmund Lattime, Stanton Gerson. |
250 ## - MENCIÓN DE EDICIÓN |
Edition statement |
Third edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Amsterdam : |
Name of producer, publisher, distributor, manufacturer |
Academic Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2014. |
300 ## - DESCRIPCIÓN FÍSICA |
Extent |
1 online resource. |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
504 ## - NOTA DE BIBLIOGRAFÍA, ETC. |
Bibliography, etc |
Includes bibliographical references and index. |
505 0# - NOTA DE CONTENIDO |
Formatted contents note |
Ex Vivo Gene Therapy: Utilization of Genetic Vectors for the Generation of Genetically Modified Cell Products for Therapy -- Targeting Tumor Vasculature Using Adeno-Associated Virus Phage Vectors Coding Tumor Necrosis Factor-a -- Viral Insertion Site Detection and Analysis in Cancer Gene Therapy -- Targeted Systemic Delivery of Therapeutic siRNA -- Bacterial Delivery of RNAi Effectors -- Gene-Directed Enzyme Prodrug Cancer Therapy -- Electroporation Gene Therapy -- Toxin-Based Cancer Gene Therapy: Under the Control of Oncofetal H19 Regulatory Sequences -- Gene Therapy in Radiotherapy of Cancer -- Advances in Oncolytic Virotherapy for Brain Tumors -- Oncolytic Adenoviruses in the Treatment of Cancer in Humans -- Selectively Replicating Oncolytic Adenoviruses Combined with Chemotherapy, Radiotherapy, or Molecular Targeted Therapy for Treatment of Human Cancers -- Reoviral Therapy for Cancer: Strategies for Improving Antitumor Efficacy Using Radio- and Chemotherapy -- Selectively Replicating Herpes Simplex Viral Vectors -- Modified Oncolytic Herpesviruses for Gene Therapy of Cancer -- The Lister Strain of Vaccinia Virus as an Anticancer Therapeutic Agent -- Poxvirus-Based Strategies for Combined Vaccine and Tumor Microenvironment Manipulation -- Genetically Engineered (T Cell Receptor) T Cells for AdoptiveTherapy -- Genetically Modified Dendritic Cell Vaccines for Solid Tumors -- Dendritic Cell Vaccination -- Chemokine Gene-Modified Dendritic Cells for Cancer Therapy -- The Use of T Cell Costimulation to Enhance the Immunogenicity of Tumors -- Clinical Application of Plasmid-Based Cancer Vaccines -- Lentivector Vaccines -- Therapeutic Efficacy and Systemic Antitumor T Cell Immunity Induced by RheoSwitch-Regulated IL-12 Expression after Intratumoral Injection of Adenovirus Vector or Vector-Transduced Dendritic Cells -- Clinical Trials Using LV-P₁₄₀K-MGMT for Gliomas -- RNA Interference Therapeutics for Tumor Therapy: Promising Work in Progress -- MGMT Stem Cell Selection and Protection: Preclinical Large Animal and Clinical Studies -- Cytidine Deaminase in Myeloprotective Gene Therapy -- Genetically Engineered Salmonella typhimurium for Targeted Cancer Therapy -- Imaging of Oncolytic Virus Gene Expression -- Lentiviral-Encoded Sodium Iodide Symporter-Mediated Cancer Gene Therapy -- Bacteriophage: From Bacteria to a Successful Targeted Systemic Gene Delivery for Cancer -- Issues in Moving Gene Therapy Approaches to Early Clinical Trials -- The FDA Review Process for Cancer Gene Therapy -- Ethics in Translational Gene Transfer Research. |
588 0# - SOURCE OF DESCRIPTION NOTE |
Source of description note |
Print version record. |
596 ## - |
-- |
19 |
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Gene therapy |
Form subdivision |
Laboratory manuals. |
650 #0 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Immunotherapy. |
650 12 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
genetics. |
650 12 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Neoplasms |
General subdivision |
therapy. |
650 22 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Genetic Therapy |
General subdivision |
methods. |
650 22 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Immunotherapy |
General subdivision |
methods. |
650 22 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Protein Biosynthesis. |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
HEALTH & FITNESS |
General subdivision |
Diseases |
-- |
General. |
Source of heading or term |
bisacsh |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Clinical Medicine. |
Source of heading or term |
bisacsh |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Diseases. |
Source of heading or term |
bisacsh |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Evidence-Based Medicine. |
Source of heading or term |
bisacsh |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Internal Medicine. |
Source of heading or term |
bisacsh |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Gene therapy. |
Source of heading or term |
fast |
Authority record control number |
(OCoLC)fst00845367 |
650 #7 - ASIENTO SECUNDARIO DE MATERIA - TERMINO TEMÁTICO |
Topical term or geographic name as entry element |
Cancer |
General subdivision |
Immunotherapy. |
Source of heading or term |
fast |
Authority record control number |
(OCoLC)fst00845386 |
655 #4 - |
-- |
Electronic books. |
655 #7 - |
-- |
Handbooks, manuals, etc. |
-- |
fast |
-- |
(OCoLC)fst01423877 |
700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL |
Personal name |
Lattime, Edmund C., |
Dates associated with a name |
1951- |
Relator term |
editor. |
700 1# - ASIENTO SECUNDARIO - NOMBRE PERSONAL |
Personal name |
Gerson, Stanton L., |
Relator term |
editor. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Relationship information |
Print version: |
Title |
Gene therapy of cancer. |
Edition |
Third edition |
International Standard Book Number |
9780123942951 |
Record control number |
(OCoLC)839312810 |
856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
Public note |
Libro electrónico |
Materials specified |
ScienceDirect |
Uniform Resource Identifier |
<a href="http://148.231.10.114:2048/login?url=http://www.sciencedirect.com/science/book/9780123942951">http://148.231.10.114:2048/login?url=http://www.sciencedirect.com/science/book/9780123942951</a> |
942 ## - TIPO DE MATERIAL (KOHA) |
Koha item type |
Libro Electrónico |